Hepatocellular carcinoma(HCC)ranks the fourth cause of cancer-related death worldwide[1].More than 50%newly diagnosed HCC patients are in China,while 70%of them
When the first series of adult-to-adult living donor liver transplantation(A2A-LDLT)were performed in Hong Kong[1],it was immediately clear that great technical
Nonalcoholic steatohepatitis(NASH),a severe type of nonalcoholic fatty liver disease(NAFLD),progresses toward liver fibrosis/cirrhosis,liver failure,and further